Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Nazik Elmalaika OS Husain & Mohamed H Ahmed. (2015) Managing dyslipidemia in HIV/AIDS patients: challenges and solutions. HIV/AIDS - Research and Palliative Care 7, pages 1-10.
Read now
Read now
Maciej Banach, Manfredi Rizzo, Peter P Toth, Michel Farnier, Michael H Davidson, Khalid Al-Rasadi, Wilbert S Aronow, Vasilis Athyros, Dragan M Djuric, Marat V Ezhov, Robert S Greenfield, G Kees Hovingh, Karam Kostner, Corina Serban, Daniel Lighezan, Zlatko Fras, Patrick M Moriarty, Paul Muntner, Assen Goudev, Richard Ceska, Stephen J Nicholls, Marlena Broncel, Dragana Nikolic, Daniel Pella, Raman Puri, Jacek Rysz, Nathan D Wong, Laszlo Bajnok, Steven R Jones, Kausik K Ray & Dimitri P Mikhailidis. (2015) Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Expert Opinion on Drug Safety 14:6, pages 935-955.
Read now
Read now
Amedeo Lonardo, Stefano Ballestri, Giovanni Targher & Paola Loria. (2015) Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 9:5, pages 629-650.
Read now
Read now
Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis & Dimitri P. Mikhailidis. (2014) Are statins ‘IDEAL’ for non-alcoholic fatty liver disease?. Current Medical Research and Opinion 30:2, pages 229-231.
Read now
Read now
Vassilios G. Athyros, Niki Katsiki, Michael Doumas, Asterios Karagiannis & Dimitri P. Mikhailidis. (2013) Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. Current Medical Research and Opinion 29:10, pages 1263-1274.
Read now
Read now
Vasilios G Athyros, Niki Katsiki, Asterios Karagiannis & Dimitri P Mikhailidis. (2013) Statins and nonalcoholic fatty liver disease: a bright future?. Expert Opinion on Investigational Drugs 22:9, pages 1089-1093.
Read now
Read now
Mohamed H Ahmed, Ayman Al-Atta & Mahir A Hamad. (2012) The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges. Expert Opinion on Pharmacotherapy 13:13, pages 1901-1909.
Read now
Read now
Niki Katsiki, Vasilios G Athyros, Asterios Karagiannis & Dimitri P Mikhailidis. (2012) Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome. Expert Opinion on Pharmacotherapy 13:2, pages 287-288.
Read now
Read now
Niki Katsiki & Moses Elisaf. (2011) Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease. Current Medical Research and Opinion 27:8, pages 1669-1672.
Read now
Read now
Articles from other publishers (17)
Musaab Ahmed, Marium Ahmed, Dushyant Mital & Mohamed H. Ahmed. 2022. Cholesterol. Cholesterol
999
1020
.
Eman D. Mohammed, Ashraf B. Abdel-Naim, Jin Kangpeng, Runqiu Jiang, Jifu Wei & Beicheng Sun. (2021) The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventer. Life Sciences 264, pages 118615.
Crossref
Crossref
Shouxing Yang, Jinwei Zhong, Mengsi Ye, Lei Miao, Guangrong Lu, Changlong Xu, Zhanxiong Xue & Xinhe Zhou. (2020) Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study. Lipids in Health and Disease 19:1.
Crossref
Crossref
Tianhui An, Yi Song, Yi Yang, Mengyuan Guo, Hui Liu, Kun Liu & Zhaohui Wang. (2018) Non-HDL-cholesterol to HDL-cholesterol ratio is an independent risk factor for liver function tests abnormalities in geriatric population. Lipids in Health and Disease 17:1.
Crossref
Crossref
Dianhui Wang, Ling Wang, Zhanqing Wang, Shihong Chen, Yihong Ni & Dongqing Jiang. (2018) Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis. Lipids in Health and Disease 17:1.
Crossref
Crossref
Elizabeth M. Masko, Mahmoud A. Alfaqih, Keith R. Solomon, William T. Barry, Christopher B. Newgard, Michael J. Muehlbauer, Nikolaos A. Valilis, Tameika E. Phillips, Susan H. Poulton, Alexis R. Freedland, Stephanie Sun, Shweta K. Dambal, Sergio E. Sanders, Everardo Macias, Michael R. Freeman, Mark W. Dewhirst, Salvatore V. Pizzo & Stephen J. Freedland. (2017) Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model. The Prostate 77:5, pages 446-457.
Crossref
Crossref
Niki Katsiki, Dimitri P. Mikhailidis & Christos S. Mantzoros. (2016) Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism 65:8, pages 1109-1123.
Crossref
Crossref
Yuval A. Patel, Carl L. Berg & Cynthia A. Moylan. (2016) Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation. Digestive Diseases and Sciences 61:5, pages 1406-1416.
Crossref
Crossref
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli & Amedeo Lonardo. (2016) The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans. Advances in Therapy 33:3, pages 291-319.
Crossref
Crossref
Konstantinos Tziomalos, Vasilios G. Athyros, Paschalis Paschos & Asterios Karagiannis. (2015) Nonalcoholic fatty liver disease and statins. Metabolism 64:10, pages 1215-1223.
Crossref
Crossref
P. Steiropoulos & N. Papanas. (2013) Continuous Positive Airway Pressure in Obstructive Sleep Apnea Syndrome and Prehypertension. Angiology 65:2, pages 93-94.
Crossref
Crossref
Konstantinos Tziomalos. (2014) Lipid-lowering agents in the management of nonalcoholic fatty liver disease. World Journal of Hepatology 6:10, pages 738.
Crossref
Crossref
Vasilios G. Athyros, Niki Katsiki & Asterios Karagiannis. (2013) Nonalcoholic Fatty Liver Disease and Severity of Cardiovascular Disease Manifestations. Angiology 64:8, pages 572-575.
Crossref
Crossref
E. Matthew Morris, Justin A. Fletcher, John P. Thyfault & R. Scott Rector. (2013) The role of angiotensin II in nonalcoholic steatohepatitis. Molecular and Cellular Endocrinology 378:1-2, pages 29-40.
Crossref
Crossref
K. H. Williams, N. A. Shackel, M. D. Gorrell, S. V. McLennan & S. M. Twigg. (2013) Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo. Endocrine Reviews 34:1, pages 84-129.
Crossref
Crossref
Irene P Tzanetakou, Ilias P Doulamis, Laskarina-Maria Korou, George Agrogiannis, Ioannis S Vlachos, Alkisti Pantopoulou, Dimitri P Mikhailidis, Efstratios Patsouris, Ioannis Vlachos & Despina N Perrea. (2012) Water Soluble Vitamin E Administration in Wistar Rats with Non-alcoholic Fatty Liver Disease. The Open Cardiovascular Medicine Journal 6:1, pages 88-97.
Crossref
Crossref
Matthias DerwallRajeev MalhotraCarol S. LaiYuko BeppuElena AikawaJasbir S. SeehraWarren M. ZapolKenneth D. BlochPaul B. Yu. (2012) Inhibition of Bone Morphogenetic Protein Signaling Reduces Vascular Calcification and Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 32:3, pages 613-622.
Crossref
Crossref